Angiogenic Activity of Hepatitis B and C Viruses | Zendy

Kristof Vrancken | Zendy; Jan Paeshuyse | Zendy; Sandra Liekens | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Angiogenic Activity of Hepatitis B and C Viruses

Author(s) -

Kristof Vrancken,

Jan Paeshuyse,

Sandra Liekens

Publication year - 2011

Publication title -

antiviral chemistry and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.919

H-Index - 51

eISSN - 2040-2066

pISSN - 0956-3202

DOI - 10.3851/imp1987

Subject(s) - hepatocellular carcinoma , angiogenesis , malignancy , immunology , medicine , hepatitis c virus , hepatitis b virus , hepatitis b , hepacivirus , virology , biology , cancer research , virus

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. The limited treatment options and poor prognosis of HCC patients underscore the importance of developing new therapeutic strategies. Infection with HBV and HCV are the major risk factors for developing HCC. While the precise molecular mechanisms that link HBV and HCV infections to the development and progression of HCC are not entirely understood, increasing evidence indicates that stimulation of angiogenesis by these viruses may contribute to HCC malignancy. In this review, we summarize the progress in understanding the role of HBV and HCV infection in liver and HCC angiogenesis, the mechanisms applied by these viruses to deregulate the angiogenic balance and the potential therapeutic options that come with this understanding.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research